Testing effectiveness (Phase 2)Ended earlyNCT03827850What this trial is testingFGFR Inhibitor in FGFR Dysregulated CancerWho this might be right forLung CancerNSCLCPulmonary Neoplasm+2 more Lung Cancer Group Cologne 22
Not applicableLooking for participantsNCT05837260What this trial is testingInvestigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid CancerWho this might be right forThyroid Cancer Royal Marsden NHS Foundation Trust 120
Not applicableLooking for participantsNCT06754423What this trial is testingElectronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase DeficiencyWho this might be right forCongenital Adrenal Hyperplasia IRCCS Azienda Ospedaliero-Universitaria di Bologna 30
Not applicableStudy completedNCT04285723What this trial is testingRetrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received AlpelisibWho this might be right forPIK3CA-Related Overgrowth Spectrum (PROS) Novartis Pharmaceuticals 57
Not applicableStudy completedNCT06355323What this trial is testingBronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, FranceWho this might be right forPrimary ImmunodeficiencyCommon Variable ImmunodeficiencyIgg Subclass Deficiency+1 more CHU de Reims 46
Large-scale testing (Phase 3)Study completedNCT00125879What this trial is testingExtension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602Who this might be right forGlycogen Storage Disease Type II Genzyme, a Sanofi Company 16
Large-scale testing (Phase 3)UnknownNCT06545526What this trial is testingChemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous PolyposisWho this might be right forFamilial Adenomatous Polyposis Yonsei University 28
Post-approval studies (Phase 4)Study completedNCT00256126What this trial is testingPredictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®Who this might be right forGrowth Hormone DeficiencyTurner Syndrome Merck KGaA, Darmstadt, Germany 318
Post-approval studies (Phase 4)Study completedNCT03406117What this trial is testingDetermine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch TestsWho this might be right forHealthyAtopic DermatitisPsoriasis Haus Bioceuticals 182
Not applicableStudy completedNCT05927740What this trial is testingThe Efficacy of Hyperemesis Gravidarum on Macular Thickness, Corneal Thickness and Intraocular Pressure in PregnancyWho this might be right forCorneal DystrophyMacular DystrophyHyperemesis Gravidarum - Severe Batman Training and Research Hospital 110
Not applicableEnded earlyNCT00078091What this trial is testingGenetics and Clinical Characteristics of Bardet-Biedl SyndromeWho this might be right forBardet-Biedl Syndrome National Human Genome Research Institute (NHGRI) 194
Testing effectiveness (Phase 2)Looking for participantsNCT06364774What this trial is testingALS20-101 Lentiviral Gene Therapy for Beta ThalassemiaWho this might be right forBeta-Thalassemia Children's Hospital of Philadelphia 12
Very early researchLooking for participantsNCT05454774What this trial is testingFVIII Gene Therapy for Hemophilia AWho this might be right forHemophilia A Institute of Hematology & Blood Diseases Hospital, China 8
Not applicableStudy completedNCT01905774What this trial is testingRenal Function Among Thalassemia Patients Treated by a Oral Chelator DeferasiroxWho this might be right forThalassemiaIron Overload HaEmek Medical Center, Israel 36
Not applicableStudy completedNCT03084497What this trial is testingEffects of Infant Massage on Development of Down Syndrome BabiesWho this might be right forDown Syndrome University of Seville 32
Not applicableActive Not RecruitingNCT05155397What this trial is testingThe Dortmund Vital Study: Impact of Biological and Lifestyle Factors on Cognitive Performace and Work AbilityWho this might be right forAge-related Cognitive Decline Technical University of Dortmund 627
Testing effectiveness (Phase 2)Looking for participantsNCT04616560What this trial is testingTrastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell TumorWho this might be right forDesmoplastic Small Round Cell TumorOsteosarcomaRecurrent Desmoplastic Small Round Cell Tumor+5 more National Cancer Institute (NCI) 55
Not applicableStudy completedNCT03684759What this trial is testingSputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic FibrosisWho this might be right forCystic FibrosisRespiratory Infection University Hospital, Brest 30
Large-scale testing (Phase 3)Study completedNCT00560378What this trial is testingLong-term Safety of Protopic in Atopic EczemaWho this might be right forDermatitis, AtopicEczema, Atopic Astellas Pharma Inc 789
Testing effectiveness (Phase 2)UnknownNCT01309178What this trial is testingAnti-inflammatory Pulmonal Therapy of Cystic Fibrosis (CF) Patients With Amitriptyline and PlaceboWho this might be right forCystic FibrosisPneumonia University Children's Hospital Tuebingen 30